Today we have a small update on the progress of the AgeMeter, a functional aging biomarker device being developed thanks to the support of the community at Lifespan.io. Elliott Small the project leader recently updated us with some positive news about how the development of the Agemeter is progressing.
We have decided to move towards the iOS/Apple ecosystem. Based on our research and experience, we believe this will hold several key advantages. To highlight a few, Apple’s closed systems and custom coding language result in a reduction in bugs and product issues down the line. Overall, it will be a more reliable product which will offer a better customer experience. The iPAD also has a universal availability with a controlled cost environment which will result in a lower cost of ownership for doctors vs the Lenovo tablets previously slated. This change in systems will present a stronger product offering overall. Some of the key changes are:
- Comprehensive iOS UI/UX design with interactive wireframes
- Frontend iOS development
- Complete backend development utilizing SQL database
- Post-launch bug & technical support
- 15 biomarker tests will be available at launch improving on the original 12 planned
- Auditory Reaction Time
- Highest Audible Pitch
- Vibrotactile Sensitivity
- Visual Reaction Time
- Muscle Movement Time
- Lung: Forced Vital Capacity
- Lung: Forced Expiratory Volume
- Decision Reaction Time
- Decision Movement Time
- Memory
- Muscle Coordination
- Vision
- Pulse Oxygen
- Heart Rate Variability
- Arterial Venous Pressure
Write a comment: